A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Conditions:  Recurrent Langerhans Cell Histiocytosis;  Refractory Langerhans Cell Histiocytosis Interventions:  Procedure: Biospecimen Collection;  Procedure: Bone Marrow Aspiration;  Procedure: Bone Marrow Biopsy;  Procedure: Computed Tomography;  Procedure: Echocardiography;  Procedure: FDG-Positron Emission Tomography and Computed Tomography Scan;  Procedure: Lumbar Puncture;  Procedure: Multigated Acquisition Scan;  Drug: Tovorafenib Sponsor:  National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | CT Scan | Histiocytosis | Langerhans Cell Histiocytosis (LCH) | Mergers and Aquisitions | PET Scan | Research | Study